Abiopharma

News list

Smith Ryan A 🔴 sold 418 shares of CAMDEN NATIONAL CORP (CAC) at $49.68 Transaction Date: Apr 24, 2026 | Filing ID: 000007

Full text

News bot April 28, 2026, 8:17 p.m.
🔍 Smith Ryan A (Executive)

Company: CAMDEN NATIONAL CORP (CAC)

Report Date: 2026-04-24
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 418
Detailed Transactions and Holdings:
- Sold 120 shares of Common Stock at $49.68 per share (Direct)
  Date: 2026-04-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 23,293.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 298 shares of Common Stock at $49.68 per share (Direct)
  Date: 2026-04-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 22,995.00 | transaction_form_type: 4 | Footnotes: F2, F3
Footnotes:
- F1: Consists of shares withheld in order to satisfy the minimum tax withholding obligation on restricted shares that vested on April 25, 2026, using the April 24, 2026 price.
- F2: Consists of shares withheld in order to satisfy the minimum tax withholding obligation on restricted stock units that were granted under the issuer's 2023-2025 Long-Term Performance Plan that vested on April 25, 2026, using the April 24, 2026 Price.
- F3: Includes 6,430 restricted stock units and restricted shares that are subject to vesting and forfeiture restrictions.